1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Brazil Pharmaceuticals and Healthcare Report Q1 2017

Brazil Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 103 pages

Includes 3 FREE quarterly updates

BMI View:
The Brazilian pharmaceutical market will stimulate greater interest from foreign multinationals in the coming years. The weakening of the Brazilian real, government efforts to promote the local pharmaceutical industry and greater international collaboration are attracting drugmakers to Latin America's largest medicines market; particularly those from Saudi Arabia and the UAE. While cooperation between Brazil and the Middle East remains in its infancy, we support a positive outlook for the future of pharmaceutical relations between the two countries.

Headline Expenditure Projections
Pharmaceuticals: BRL66.79bn (USD20.05bn) in 2015 to BRL71.73bn (USD20.61bn) in 2016; +7.4% in local currency terms and 2.8% in US dollar terms. Forecast in local currency terms is unchanged from last quarter. Healthcare: BRL497.61bn (USD149.38bn) in 2015 to BRL538.07bn (USD154.62bn) in 2016; +8.1% in local currency terms and +3.5% in US dollar terms. Forecast in local currency terms revised downward from last quarter due to new historical data.

Table Of Contents

Brazil Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Brazil 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Brazil 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Brazil 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Brazil 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Brazil 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Brazil 2014-2020) 30
Industry Risk/Reward Index 31
Americas Risk/Reward Index 31
Brazil Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Intellectual Property Issues 39
Pricing Regime 41
Reimbursement Regime 43
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Brazil 2010-2015) 47
Table: Healthcare Personnel (Brazil 2010-2015) 48
Table: Healthcare Activity (Brazil 2010-2015) 48
Research and Development 49
Biotechnology 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 56
Research-Based Industry 56
Table: Top 10 Pharmaceutical Companies In Brazil By Sales In 2013 56
Table: Multinational Pharmaceutical Company Activity 57
Generic Drugmakers 57
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 61
Company Profile 63
Ache/Biosintetica 63
Cristália 66
EMS Sigma 69
Eurofarma 72
GlaxoSmithKline 74
Medley 77
Merck and Co 79
Novartis 81
Pfizer 84
Roche 87
Sanofi 89
Demographic Forecast 92
Table: Population Headline Indicators (Brazil 1990-2025) 93
Table: Key Population Ratios (Brazil 1990-2025) 93
Table: Urban/Rural Population and Life Expectancy (Brazil 1990-2025) 94
Table: Population By Age Group (Brazil 1990-2025) 94
Table: Population By Age Group % (Brazil 1990-2025) 95
Glossary 97
Methodology 99
Pharmaceutical Expenditure Forecast Model 99
Healthcare Expenditure Forecast Model 99
Notes On Methodology 100
Risk/Reward Index Methodology 101
Index Overview 102
Table: Pharmaceutical Risk/Reward Index Indicators 102
Indicator Weightings 103

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.